"This is inform that the ongoing disputes at various courts between the company and various group companies of Procter & Gamble Inc. In India, have been settled with mutual consent and concluded positively for JHS," JHS Svendgaard Laboratories said in a BSE filing.
In reaction to the announcement, shares of JHS Svendgaard Laboratories were trading 7.85 per cent higher at Rs 57 on the BSE.
The company further said: "The settlements clears contingent liabilities to the tune of Rs 206.15 crore, from the balance sheets of JHS."